Targeted Therapy in Epithelial Ovarian Cancer

Kelsey Thomas Butler University
Faculty Sponsor(s): Patience Masamha Butler University
According to the National Cancer Institute, in 2018 there were more than 22,000 new cases of epithelial ovarian cancer and over 14,000 deaths making it the eighth most common cause of cancer-related deaths in women. With no reliable diagnostic approaches, a lack of attributing early symptoms, and a high rate of relapse, epithelial ovarian cancer is in need of further research and treatment improvements. The goal of this study was to look into the gene mutations occurring in ovarian cancer and evaluate targeted therapy treatment options based on those mutations. By comparing gene mutations found on genetic testing registries for ovarian cancer to the therapies in current guidelines as well as those in clinical trials, this study could provide insight into genetic targets that have not yet been pursued as treatment options. Results will be discussed during the presentation as research is still ongoing.
Pharmacy, Health Sciences, & Exercise Science
Oral Presentation

When & Where

02:00 PM
Pharmacy & Health Sciences 212